Legal Workshop: Choosing the Right Form of Entity
Join the Harlem Biospace member companies and attorneys from our flagship partner WilmerHale for the first in a series of workshops on legal topics for biotech ventures. This session is focused on considerations for choosing the business entity type of your biotech venture.
Instructors and Moderators
Jennifer Berrent, Partner, WilmerHale
Jennifer Berrent has handled a variety of corporate and securities law matters for a number of entrepreneurs, early-stage investors and established companies. Ms. Berrent has routinely advised on complex transactions, including mergers and acquisitions, venture capital financings and initial public offerings, among others. Using her business background, Ms. Berrent has advised clients on how to adapt their business models and has regularly provided advice and representation to emerging companies and clients in the FinTech sector. Before law school, she was a strategy consultant at The Parthenon Group and worked in the Strategic Planning Group at American Express.
Ms. Berrent has been working with emerging companies in particular for more than 15 years and is focused on serving as trusted advisor to entrepreneurs and the NYC entrepreneurial community. She represents first-time and serial entrepreneurs, as well as early stage investors and venture capital funds. She spearheaded the firm’s involvement with WeWork Labs, a leading start-up incubator program, to offer accessible legal counsel and programming for early stage entrepreneurs.
Ian Wildgoose Brown, Associate, WilmerHale
Ian Wildgoose Brown has a general corporate practice with an emphasis on mergers and acquisitions and capital markets transactions for companies at all stages of growth. He regularly advises emerging companies with respect to a wide range of issues, including debt and equity financings and general corporate matters. He is also a member of the firm’s FinTech Group.
Prior to joining WilmerHale, Mr. Wildgoose Brown was a summer associate with the Toronto office of Davies Ward Phillips & Vineberg LLP, where he focused on general corporate and securities law matters.